Literature DB >> 11086034

Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo.

R J Binder1, K M Anderson, S Basu, P K Srivastava.   

Abstract

Immunization of mice with the heat shock protein (HSP) gp96 but not control proteins leads to 5- to 7-fold enlargement of draining lymph nodes (LNs) resulting from accumulation of large numbers of mature CD11c(+) cells, but not T or B lymphocytes in them. The increase in size and cellularity is time-dependent; the draining LNs reach their peak size between 12 and 24 h after injection and regress to their normal size between 48 and 72 h after injection. The increment is elicited specifically in the draining LN but not in other LNs. This observation uncovers a novel aspect of HSP-APC interaction and adds to the mechanistic explanation for the unusually high immunogenicity of HSP-peptide complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086034     DOI: 10.4049/jimmunol.165.11.6029

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Heat shock proteins and innate immunity.

Authors:  J S H Gaston
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  Bacterial stimulation upregulates the surface expression of the stress protein gp96 on B cells in the frog Xenopus.

Authors:  Heidi Morales; Alma Muharemagic; Jennifer Gantress; Nicholas Cohen; Jacques Robert
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

4.  High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.

Authors:  Toyoshi Matsutake; Tatsuya Sawamura; Pramod K Srivastava
Journal:  Cancer Immun       Date:  2010-08-02

Review 5.  Dendritic Cell-Based Cancer Vaccines.

Authors:  Patricia M Santos; Lisa H Butterfield
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

Review 6.  Natural endogenous adjuvants.

Authors:  Kenneth L Rock; Arron Hearn; Chun-Jen Chen; Yan Shi
Journal:  Springer Semin Immunopathol       Date:  2004-10-14

Review 7.  SUMO wrestling with type 1 diabetes.

Authors:  Manyu Li; Dehuang Guo; Carlos M Isales; Decio L Eizirik; Mark Atkinson; Jin-Xiong She; Cong-Yi Wang
Journal:  J Mol Med (Berl)       Date:  2005-04-02       Impact factor: 4.599

Review 8.  Stress proteins and initiation of immune response: chaperokine activity of hsp72.

Authors:  Alexzander Asea
Journal:  Exerc Immunol Rev       Date:  2005       Impact factor: 6.308

9.  Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.

Authors:  Michelle Nicole Messmer; Joshua Pasmowitz; Laura Elizabeth Kropp; Simon C Watkins; Robert Julian Binder
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

10.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.